The resolution of two listing deficiencies removes immediate delisting risk from those specific rules, but the outstanding periodic reporting delinquency (Rule 5250(c)(1)) remains a material overhang. Monitor for completion of delayed filings (10-K/10-Qs) as the next catalyst; failure to file could trigger a new delisting proceeding. The stock's low market cap ($41M) and history of volatile moves on regulatory news suggest binary risk.
Price Chart
Executive Summary
Celularity regained compliance with Nasdaq's minimum bid price (Rule 5550(a)(2)) and minimum market value of listed securities (Rule 5550(b)(2)) requirements, closing those deficiencies. However, the company's previously disclosed delinquency under Nasdaq Listing Rule 5250(c)(1) for delayed periodic reports remains outstanding, and the company continues working to complete its delayed filings. The resolution of two listing deficiencies is a modest positive, but the persistent reporting delinquency keeps the stock at risk of delisting.
Key Facts
- Regained compliance with Nasdaq minimum bid price (Rule 5550(a)(2)) and minimum market value of listed securities (Rule 5550(b)(2)) on September 11, 2026.
- Nasdaq confirmed both matters are now closed.
- The previously disclosed deficiency under Nasdaq Listing Rule 5250(c)(1) for delayed periodic reports remains outstanding.
- Company continues to work to complete its delayed filings and regain compliance with Nasdaq's periodic reporting requirement.
- Market cap is approximately $41M, and 86% of analysts rate the stock as Buy or Strong Buy.
Financial Impact
No financial figures provided in the filing. The company's market cap is approximately $41M.
Risk Factors
- Failure to complete delayed periodic reports could lead to delisting from Nasdaq.
- Low market capitalization ($41M) makes the stock vulnerable to large percentage moves on any news.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 8 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (CELU) — Batch item 1 | 0001493152-26-042495 |
| Document: 0001493152-26-042495-index-headers.html | 0001493152-26-042495 |
| Document: 0001493152-26-042495-index.html | 0001493152-26-042495 |
| Document: 0001493152-26-042495.txt | 0001493152-26-042495 |
| 8-K Filing (CELU) — Batch item 5 | 0001493152-26-042495 |
| Document: 0001493152-26-042495-index-headers.html | 0001493152-26-042495 |
| Document: 0001493152-26-042495-index.html | 0001493152-26-042495 |
| Document: 0001493152-26-042495.txt | 0001493152-26-042495 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 20, 2026 6d ago | 10-K/A | $1.26 | awaiting T+60 | — | $0.9457 (+24.94%) |
Sep 30, 2026 26d ago | Press Release | $1.35 | awaiting T+60 | — | $0.9457 (−29.95%) |
Sep 29, 2026 26d ago | 8-K | $1.35 | awaiting T+60 | — | $0.9457 (−29.95%) |
Sep 28, 2026 28d ago | SC 13D/A | $1.40 | awaiting T+60 | — | $0.9457 (+32.45%) |
Sep 28, 2026 28d ago | 8-K | $1.40 | awaiting T+60 | — | $0.9457 (+32.45%) |
Sep 24, 2026 4w ago | Press Release | $1.32 | awaiting T+60 | — | $0.9457 (−28.36%) |
Sep 14, 2026 6w ago | 8-K | $1.40 | awaiting T+60 | — | $0.9457 (−32.45%) |
Aug 25, 2026 8w ago | Press Release | $0.8804 | awaiting T+60 | — | $0.9457 (−7.42%) |
Aug 7, 2026 11w ago | 8-K | $0.6866 | awaiting T+60 | — | $0.9457 (−37.74%) |
Jun 30, 2026 16w ago | 8-K | $0.5979 $1.15 | ▼ −92.34% | ▼ −88.78% | $0.9457 (−58.17%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers